// App-Quantinova.ai

TCT-832 : Resting Heart Rate at Discharge Predicts Adverse Cardiovascular Outcomes In Patients With Left Main Coronary Artery Disease Revascularized With PCI and CABG: Insights from the EXCEL trial

Researchers

Presenter

  • Ioanna Kosmidou

Principal Investigators

  • Aaron Crowley

  • Leon Gustavo Macedo

  • Ori Ben-Yehuda

  • Bernard Gersh

  • Ad Van Boven

  • Piet Willem Boonstra

  • A. Pieter Kappetein

  • Patrick Serruys

  • Joseph Sabik

  • Gregg Stone

Medical Centers

  • Columbia University, New York, New York, United States

  • Mayo Clinic, Rochester, Minnesota, United States

  • Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, United States

  • Medisch Centrum Leeuwarden, Heart Center, Leeuwarden PObox 888, Netherlands

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Cardiovascular Research Foundation, Queens, New York, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Imperial College, London, United Kingdom

  • Medisch Centrum Leeuwarden, Haren, Netherlands

Locations

  • United States

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved